Alexandra Toohey
@Baker Bros. Advisors Lp
Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.
Assets under management
The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
4576⤦Insmed Incorporated
| 0% | $56.192M 32.887M shares@ $1.71 avg price | Exited |
CERECerevel Therapeutics Holdings, Inc.
| 0% | $27.952M 683,588 shares@ $40.89 avg price | Exited |
ATHAAthira Pharma, Inc.
| 0% | $8.358M 3.154M shares@ $2.66 avg price | Exited |
TLISTalis Biomedical Corporation
| 0% | $4.403M 508,323 shares@ $8.67 avg price | Exited |
ADAPAdaptimmune Therapeutics Plc
| 0% | $2.285M 2.344M shares@ $0.98 avg price | Exited |
SAGESage Therapeutics, Inc.
| 0% | $1.857M 171,026 shares@ $10.86 avg price | Exited |
ACHLAchilles Therapeutics Plc
| 0% | $903,645 1.109M shares@ $0.82 avg price | Exited |
ALGSAligos Therapeutics, Inc.
| 0% | $726,740 2.076M shares@ $0.35 avg price | Exited |